Oregon Bioscience Association’s Government Affairs and Advocacy Priorities Platform
Oregon Bio works with its member companies and organizations to develop its robust advocacy agenda. Progress comes as the result of high member engagement, co-opted strategy, careful planning and tireless effort. Whether to protect patient access to medicines, increase market access or financing for companies, activation toward capitalization and commercialization policy, or implementing the new Oregon Investment Act, the bioscience industry and Oregon Bio are impacting the marketplace now more than ever.
The Oregon Bioscience Association’s Government Affairs and Advocacy Committee and Board of Directors are pleased with the results of the 2016 legislative session and are looking to continue the momentum for Oregon’s long session in 2017.
The Biotechnology Industry Organization (BIO) has developed this 2015 report of noteworthy public policy strategies and programs to assist policy leaders and their bioscience industry partners in identifying new and innovative measures to create, nurture, and retain the bioscience industry.